An exploration of the prevalence and experience of cardiac cachexia: protocol for a mixed methods cross-sectional study

Matthew Carson, Joanne Reid, Loreena Hill, Lana Dixon, Patrick Donnelly, Paul F Slater, Alyson Hill, Donna Fitzsimons

Research output: Contribution to journalArticle

Abstract

Background
Cachexia is a complex and multifactorial syndrome defined as severe weight loss and muscle wasting which frequently goes unrecognised in clinical practice [1]. It is a debilitating syndrome, resulting in patients experiencing decreased quality of life and an increased risk of premature death; with cancer cachexia alone resulting in 2 million deaths per annum [2]. Most work in this field has focused on cancer cachexia, with cardiac cachexia being relatively understudied – despite its potential prevalence and impact in patients who have advanced heart failure. We report here the protocol for an exploratory study which will: 1. focus on determining the prevalence and clinical implications of cardiac cachexia within advanced heart failure patients; and 2. explore the experience of cachexia from patients’ and caregivers’ perspectives.

Methods
A mixed methods cross-sectional study. Phase 1: A purposive sample of 362 patients with moderate to severe heart failure from two Trusts within the United Kingdom will be assessed for known characteristics of cachexia (loss of weight, loss of muscle, muscle mass/strength, anorexia, fatigue and selected biomarkers), through basic measurements (i.e. mid-upper arm circumference) and use of three validated questionnaires; focusing on fatigue, quality of life and appetite. Phase 2: Qualitative semi-structured interviews with patients (n = 12) that meet criteria for cachexia, and their caregivers (n = 12), will explore their experience of this syndrome and its impact on daily life. Interviews will be digitally recorded and transcribed verbatim, prior to qualitative thematic and content analysis. Phase 3: Workshops with key stakeholders (patients, caregivers, healthcare professionals and policy makers) will be used to discuss study findings and identify practice implications to be tested in further research.

Discussion
Data collected as part of this study will allow the prevalence of cardiac cachexia in a group of patients with moderate to severe heart failure to be determined. It will also provide a unique insight into the implications and personal experience of cardiac cachexia for both patients and carers. It is hoped that robust quantitative data and rich qualitative perspectives will promote crucial clinical discussions on implications for practice, including targeted interventions to improve patients’ quality of life where appropriate.
LanguageEnglish
Article number82
Number of pages11
JournalBMC Palliative Care
Volume18
Issue number1
DOIs
Publication statusPublished - 20 Oct 2019

Fingerprint

Cachexia
Cross-Sectional Studies
Caregivers
Heart Failure
Quality of Life
Fatigue
Weight Loss
Interviews
Muscles
Premature Mortality
Muscle Strength
Anorexia
Appetite
Administrative Personnel
Neoplasms
Arm
Biomarkers
Delivery of Health Care
Education

Keywords

  • Cachexia
  • Cardiac cachexia
  • Heart failure
  • Palliative care
  • mixed methods
  • Cross-sectional study

Cite this

Carson, Matthew ; Reid, Joanne ; Hill, Loreena ; Dixon, Lana ; Donnelly, Patrick ; Slater, Paul F ; Hill, Alyson ; Fitzsimons, Donna. / An exploration of the prevalence and experience of cardiac cachexia: protocol for a mixed methods cross-sectional study. In: BMC Palliative Care. 2019 ; Vol. 18, No. 1.
@article{a77fc93776424d71874080ab2ac7796f,
title = "An exploration of the prevalence and experience of cardiac cachexia: protocol for a mixed methods cross-sectional study",
abstract = "BackgroundCachexia is a complex and multifactorial syndrome defined as severe weight loss and muscle wasting which frequently goes unrecognised in clinical practice [1]. It is a debilitating syndrome, resulting in patients experiencing decreased quality of life and an increased risk of premature death; with cancer cachexia alone resulting in 2 million deaths per annum [2]. Most work in this field has focused on cancer cachexia, with cardiac cachexia being relatively understudied – despite its potential prevalence and impact in patients who have advanced heart failure. We report here the protocol for an exploratory study which will: 1. focus on determining the prevalence and clinical implications of cardiac cachexia within advanced heart failure patients; and 2. explore the experience of cachexia from patients’ and caregivers’ perspectives.MethodsA mixed methods cross-sectional study. Phase 1: A purposive sample of 362 patients with moderate to severe heart failure from two Trusts within the United Kingdom will be assessed for known characteristics of cachexia (loss of weight, loss of muscle, muscle mass/strength, anorexia, fatigue and selected biomarkers), through basic measurements (i.e. mid-upper arm circumference) and use of three validated questionnaires; focusing on fatigue, quality of life and appetite. Phase 2: Qualitative semi-structured interviews with patients (n = 12) that meet criteria for cachexia, and their caregivers (n = 12), will explore their experience of this syndrome and its impact on daily life. Interviews will be digitally recorded and transcribed verbatim, prior to qualitative thematic and content analysis. Phase 3: Workshops with key stakeholders (patients, caregivers, healthcare professionals and policy makers) will be used to discuss study findings and identify practice implications to be tested in further research.DiscussionData collected as part of this study will allow the prevalence of cardiac cachexia in a group of patients with moderate to severe heart failure to be determined. It will also provide a unique insight into the implications and personal experience of cardiac cachexia for both patients and carers. It is hoped that robust quantitative data and rich qualitative perspectives will promote crucial clinical discussions on implications for practice, including targeted interventions to improve patients’ quality of life where appropriate.",
keywords = "Cachexia, Cardiac cachexia, Heart failure, Palliative care, mixed methods, Cross-sectional study",
author = "Matthew Carson and Joanne Reid and Loreena Hill and Lana Dixon and Patrick Donnelly and Slater, {Paul F} and Alyson Hill and Donna Fitzsimons",
year = "2019",
month = "10",
day = "20",
doi = "10.1186/s12904-019-0471-0",
language = "English",
volume = "18",
journal = "BMC Palliative Care",
issn = "1472-684X",
publisher = "BioMed Central",
number = "1",

}

An exploration of the prevalence and experience of cardiac cachexia: protocol for a mixed methods cross-sectional study. / Carson, Matthew ; Reid, Joanne; Hill, Loreena; Dixon, Lana; Donnelly, Patrick; Slater, Paul F; Hill, Alyson; Fitzsimons, Donna.

In: BMC Palliative Care, Vol. 18, No. 1, 82, 20.10.2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - An exploration of the prevalence and experience of cardiac cachexia: protocol for a mixed methods cross-sectional study

AU - Carson, Matthew

AU - Reid, Joanne

AU - Hill, Loreena

AU - Dixon, Lana

AU - Donnelly, Patrick

AU - Slater, Paul F

AU - Hill, Alyson

AU - Fitzsimons, Donna

PY - 2019/10/20

Y1 - 2019/10/20

N2 - BackgroundCachexia is a complex and multifactorial syndrome defined as severe weight loss and muscle wasting which frequently goes unrecognised in clinical practice [1]. It is a debilitating syndrome, resulting in patients experiencing decreased quality of life and an increased risk of premature death; with cancer cachexia alone resulting in 2 million deaths per annum [2]. Most work in this field has focused on cancer cachexia, with cardiac cachexia being relatively understudied – despite its potential prevalence and impact in patients who have advanced heart failure. We report here the protocol for an exploratory study which will: 1. focus on determining the prevalence and clinical implications of cardiac cachexia within advanced heart failure patients; and 2. explore the experience of cachexia from patients’ and caregivers’ perspectives.MethodsA mixed methods cross-sectional study. Phase 1: A purposive sample of 362 patients with moderate to severe heart failure from two Trusts within the United Kingdom will be assessed for known characteristics of cachexia (loss of weight, loss of muscle, muscle mass/strength, anorexia, fatigue and selected biomarkers), through basic measurements (i.e. mid-upper arm circumference) and use of three validated questionnaires; focusing on fatigue, quality of life and appetite. Phase 2: Qualitative semi-structured interviews with patients (n = 12) that meet criteria for cachexia, and their caregivers (n = 12), will explore their experience of this syndrome and its impact on daily life. Interviews will be digitally recorded and transcribed verbatim, prior to qualitative thematic and content analysis. Phase 3: Workshops with key stakeholders (patients, caregivers, healthcare professionals and policy makers) will be used to discuss study findings and identify practice implications to be tested in further research.DiscussionData collected as part of this study will allow the prevalence of cardiac cachexia in a group of patients with moderate to severe heart failure to be determined. It will also provide a unique insight into the implications and personal experience of cardiac cachexia for both patients and carers. It is hoped that robust quantitative data and rich qualitative perspectives will promote crucial clinical discussions on implications for practice, including targeted interventions to improve patients’ quality of life where appropriate.

AB - BackgroundCachexia is a complex and multifactorial syndrome defined as severe weight loss and muscle wasting which frequently goes unrecognised in clinical practice [1]. It is a debilitating syndrome, resulting in patients experiencing decreased quality of life and an increased risk of premature death; with cancer cachexia alone resulting in 2 million deaths per annum [2]. Most work in this field has focused on cancer cachexia, with cardiac cachexia being relatively understudied – despite its potential prevalence and impact in patients who have advanced heart failure. We report here the protocol for an exploratory study which will: 1. focus on determining the prevalence and clinical implications of cardiac cachexia within advanced heart failure patients; and 2. explore the experience of cachexia from patients’ and caregivers’ perspectives.MethodsA mixed methods cross-sectional study. Phase 1: A purposive sample of 362 patients with moderate to severe heart failure from two Trusts within the United Kingdom will be assessed for known characteristics of cachexia (loss of weight, loss of muscle, muscle mass/strength, anorexia, fatigue and selected biomarkers), through basic measurements (i.e. mid-upper arm circumference) and use of three validated questionnaires; focusing on fatigue, quality of life and appetite. Phase 2: Qualitative semi-structured interviews with patients (n = 12) that meet criteria for cachexia, and their caregivers (n = 12), will explore their experience of this syndrome and its impact on daily life. Interviews will be digitally recorded and transcribed verbatim, prior to qualitative thematic and content analysis. Phase 3: Workshops with key stakeholders (patients, caregivers, healthcare professionals and policy makers) will be used to discuss study findings and identify practice implications to be tested in further research.DiscussionData collected as part of this study will allow the prevalence of cardiac cachexia in a group of patients with moderate to severe heart failure to be determined. It will also provide a unique insight into the implications and personal experience of cardiac cachexia for both patients and carers. It is hoped that robust quantitative data and rich qualitative perspectives will promote crucial clinical discussions on implications for practice, including targeted interventions to improve patients’ quality of life where appropriate.

KW - Cachexia

KW - Cardiac cachexia

KW - Heart failure

KW - Palliative care

KW - mixed methods

KW - Cross-sectional study

UR - http://www.scopus.com/inward/record.url?scp=85073623102&partnerID=8YFLogxK

U2 - 10.1186/s12904-019-0471-0

DO - 10.1186/s12904-019-0471-0

M3 - Article

VL - 18

JO - BMC Palliative Care

T2 - BMC Palliative Care

JF - BMC Palliative Care

SN - 1472-684X

IS - 1

M1 - 82

ER -